Anemia in inflammatory bowel disease;L'anemia nelle malattie infiammatorie croniche intestinali

Minerva Gastroenterologica e Dietologica

Volumn 52, Issue 3, 2006, Pages 275-291

  Giannini, S ^a   Martes, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Anemia; Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; IRON; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CHRONIC DISEASE; CLINICAL TRIAL; COLON CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ENTERITIS; FOLIC ACID DEFICIENCY; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; IRON DEFICIENCY ANEMIA; IRON THERAPY; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; VITAMIN SUPPLEMENTATION;

ANEMIA; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANEMIA, IRON-DEFICIENCY; CHRONIC DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; MYELODYSPLASTIC SYNDROMES;

EID: 33750628108     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of literature. Am J Med 2004;116(7A):44S-9S.
2. Cronin CC, Shanahan F. Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol 2001;96:2296-8.
3. Nemeth E, Riviera S, Gabayan V, Keller C, Taudorf S, Pedersen BK et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6.
4. Lomer MC, Kodjabashia K, Hutchinson C, Greenfield SM, Thompson RP, Powell JJ. Intake of dietary iron is low in patients with Crohn's disease: a case-control study. Br J Nutr 2004;91:141-8.
5. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
6. Alvarez-Hernandez X, Liceaga J, McKay IC, Brock JH. Induction of hypoferritinemia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 1989;61:319-22.
7. Ludwiczek S, Aigner E, Theurl I, Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003;101:4148-54.
8. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest 2004;113:1251-3.
9. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL. Decreased erythropoietin response in patients with anemia of cancer. N Engl J Med 1990;322:1689-92.
10. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 1998;18:555-9.
11. Means RT Jr. Recent developments in the anemia of chronic disease. Curr Hematol Rep 2003;2:116-21.
12. Maciejewski JP, Selleri C, Stato T, Cho HJ, Keefer LK, Nathan CF et al. Nitric oxide suppression of human hematopoiesis in vitro: contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest 1995;96:1085-92.
13. Spivak JL. Iron and the anemia of chronic disease. Oncology (Huntingt) 2002;16 Suppl 10:25-33.
14. Behrend C, Jeppesen PB, Mortensen PB. Vitamin B12 absorption after ileorectal anastomosis for Crohn's disease: effect of ileal resection and time span after surgery. Eur J Gastroenterol Hepatol 1995;7:397-400.
15. Dunn AM, Kerr GD. Pure red cell aplasia associated with sulphasalazine. Lancet 1981;2:1288.
16. Abboudi ZH, Marsh JC, Smith-Laing G, Gordon-Smith EC. Fatal aplastic anemia after mesalazine. Lancet 1994;343:542.
17. Goodacre RL, Ali M, Vanderlinden B, Hamilton J, Castelli M, Seaton T. Hemolytic anemia in patients reciving sulfasalazina. Digestion 1978;17:503-8.
18. Giannadaki E, Potamianos S, Roussomoustakaki M, Kyriakou D, Fragkiadakis N, Manousos ON. Autoimmune haemolytic anemia and positive coombs test associated with ulcerative colitis. Am J Gastroenterol 1997;92:1872-4.
19. Veloso FT, Fraga J, Carvalho J Dias LM, Salgado MC. Autoimmune hemolytic anemia in ulcerative colitis. A case report with review of the literature. J Clin Gastroenterol 1991;13:445-7.
20. Ng JP, Soliman A, Kumar B, Lam DC. Auto-immune haemolytic anemia and Crohn's disease: a case report and review of the literature. Eur J Gastroenterol Hepatol 2004;16:417-9.
21. Plikat K, Rogler G, Schölmerich J. Coombs-positive autoimmune hemolytic anemia in Crohn's disease. Eur J Gastroenterol Hepatol 2005;17:661-6.
22. Hochmann JA. Autoimmune hemolytic anemia associated with Crohn's disease. Inflamm Bowel Dis 2002;8:98-100.
23. Fong S, Fudemberg H, Perlman P. Ulcerative colitis with antierythrocyte antibodies. Vox Sang (Basel) 1963;8:668-79.
24. Yates P, Macht LM, Williams NA, Elson CJ. Red cell autoantibody production by colonic onuclear cells from a patient with ulcerative colitis and autoimmune haemolytic anemia. Br J Hematol 1992;82:753-6.
25. Iwama T, Imajo M, Mishima Y. Coombs-positive autoimmune hemolytic anemia in ulcerative colitis: a report of two cases. Jpn J Surg 1991;21:341-3.
26. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000;47:487-96.
27. Gumaste V, Greenstein AJ, Meyers R, Sachar DB. Coombs-positive autoimmune hemolytic anemia in ulcerative colitis. Dig Dis Sci 1989;34:l457-61.
28. Boberg KM, Brinch L, Vain M. Crohn's disease and the myelodysplastic syndrome. Ann Intern Med 1995;122:395-403.
29. Hebbar M, Kozlowski D, Wattel E, Mastrini S, Dievart M, Duclos B et al. Association between myelodysplastic syndromes and inflammatory bowel disease. Report of seven new cases and review of the literature. Leukemia 1997;11:2188-91.
30. Tani T, Sakai Y, Ohtake M, Hatakeyama K. Simultaneous development of Crohn's disease and myelodysplastic syndrome progressing to acute myelocytic leukemia in a patient with normal karyotype. J Gastroenterol 1996;31:599-602.
31. Harewood GC, Loftus EV Jr, Tefferi A, Tremaine WJ, Sandborn WJ. Concurrent inflammatory bowel disease and myelodysplastic syndromes. Inflamm Bowel Dis 1999;5:98-103.
32. Hamblin TJ. Immunologic abnormalities in myelodysplastic syndromes. Semin Hematol 1996;33:150-62.
33. Reimund JM, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baurmann R et al. Increased production of tumor necrosis factor α, interleukin-1β, and interleukin 6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996;39:684-9.
34. Nisse C, Iorthois C, Drop V, Eloy E, Haguenoer JM, Penaux P. Exposure to occupational and environmental factors in myelodysplastic sundromes. Preliminary results of case control study. Leukemia 1995;9:693-9.
35. Koutroubakis I, Manousos ON, Meuwissen SGM, Pena AS. Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology 1996;43:381-93
36. Thomson ABR, Brust R, Ali MAM, Mant MJ, Valberg LS. Iron deficiency in inflammatory bowel disease. Diagnostic efficacy of serum ferritin. Am J Dig Dis 1978;23:705-9.
37. Kohgo Y, Nishisato T, Kondo H, Nobuyasu T, Niitsu Y, Urushizaki I. Circulating transferrin receptor in human serum. Br J Haematol 1986;64:277-81.
38. Colton C, Geraci K, Tahsildar H, Flowers CM, Cook J, Cooper G et al. Serum transreceptor/ferritin ratio is a reliable predictor of iron deficiency anemia in inflammatory bowel disease patients. Am J Gastroenterol 1995;108:A800.
39. Ferguson BJ, Skikne BS, Simpson KM, Bayens RD, Cook JD. Serum transferring receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1992;119:385-90.
40. Punnonen K, Irjala K, Rajamaki A. Serum transferring receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;80:1052-7.
41. Revel-Vilk S, Tamary H, Broide E, Zoldan M, Dinari G, Zahavi I et al. Serum transferring receptor in children and adolescents with inflammatory bowel disease. Eur J Pediatr 2000;159:585-9.
42. Christodoulou DK, Tsianos EV. Anemia in inflammatory bowel disease: the role of recombinant human erythropoietin. Eur J Inter Med 2000;11:222-7.
43. Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasche C et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996;334:619-23.
44. Ludwig H, Friz E, Leitgeb C, Pecherstorfer M, Samonigg H, Schustr J. Prediction of response to erytropoietin treatment in chronic anemia of cancer. Blood 1994;84:1056-63.
45. Henry H, Abels R, Larholt K. Prediction of response to recombinant human erytropoietin (r-HuEPO/epoetin-alpha) therapy in cancer patients. Blood 1995;85:1676-8.
46. Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 2003;38:543-8.
47. Fishbane S, Wagner J. Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis. Am J Kidney Dis 2001;37:879-83.
48. Michael B, Coyne DW, Fishbane S, Folkert V, Lynn R, Nissenson AR et al. Sodium ferric gluconate complex in hemodyalisis patients: adverse reactions compared to placebo and iron dextran. Kidney Int 2002;61:1830-9.
49. Yee J, Bersarab A. Iron sucrose: the oldest iron therapy becames new. Am J Kidney Dis 2002;40:1111-21.
50. Gasche C, Dejaco C, Reinisch W, Tillinger W, Waldhoer T, Fueger GF et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. Digestion 1999;60:262-7.
51. Gasche C, Waldhoer T, Feichenschlager T, Male C, Mayer A, Mittermaier C et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 2001;96:2382-7.
52. Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G. Effect of iron treatment on circulating cytokine levels in ESRD patients reciving recombinant human erythropoietin. Kidney Int 2003;64:572-8.
53. Means RT Jr, Krantz SB. Inhibition of human erythroid colony-forming units by gamma interferon can be correct by recombinant human erytropoietin. Blood 1991;78:2564-7.
54. Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the Ameri-can Society of Hematology. J Clin Oncol 2002;20:4083-107.
55. Horina JH, Petritsch W, Schmid CR, Reicht G, Wenzl H, Silly H et al. Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: results in three patients. Gastroenterol 1993;104:1828-31.
56. Gasche C, Reinisch W, Lochs H, Parsaei B, Bakos S, Wyatt J et al. Anemia in Crohn's disease. Dig Dis Sci 1994;39:1930-4.
57. Demirturk L, Hulagu S, Yahlaci M, Atlin M, Ozel M. Serum eryth levels in patients with severe anemia secondary to inflammatory bowel disease and use of recombinant human erythropoietin in patients with anemia refractory to treatment. Dis Col Rectum 1995;38:896-7.
58. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405.
59. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF et al. Maintenance infliximab for Crohn's disease: The ACCENT I randomized trial. Lancet 2002;359:1541-9.
60. Orchard T. Extraintestinal complications of inflammatory bowel disease. Curr Gastroenterol Rep 2003;5:512-7.
61. Domènech E, Manosa M, Masnou, Navarro M, Garcia-Planella E, Bernal I et al. Infliximab for the treatment of chronic anemia in Crohn's disease. Am J Gastroenterol 2005;100:496.
62. Shashaty GG, Rath CE, Britt J. Autoimmune hemolytic anemia associated with ulcerative colitis. Am J Hematol 1977;3:199-208.
63. Lang B, Weber S, Maas D. Autoimmune hemolytic anemia in ulcerative colitis: report of 7 cases, possible treatment and review of the literature. Schweiz Med Wochenschr 1985;115:897-902.
64. Basista MH, Roe DC. A case presentation of hemolytic anemia in ulcerative colitis and review of the literature. Am J Gastroenterol 1986;81:990-2.